GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Barak Investment House Ltd (XTAE:BARI) » Definitions » Debt-to-Equity

Barak Investment House (XTAE:BARI) Debt-to-Equity : -1.02 (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Barak Investment House Debt-to-Equity?

Barak Investment House's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₪15.51 Mil. Barak Investment House's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₪20.88 Mil. Barak Investment House's Total Stockholders Equity for the quarter that ended in Dec. 2023 was ₪-35.62 Mil. Barak Investment House's debt to equity for the quarter that ended in Dec. 2023 was -1.02.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Barak Investment House's Debt-to-Equity or its related term are showing as below:

XTAE:BARI' s Debt-to-Equity Range Over the Past 10 Years
Min: -1.76   Med: 0.28   Max: 1.42
Current: -1.02

During the past 8 years, the highest Debt-to-Equity Ratio of Barak Investment House was 1.42. The lowest was -1.76. And the median was 0.28.

XTAE:BARI's Debt-to-Equity is not ranked
in the Drug Manufacturers industry.
Industry Median: 0.29 vs XTAE:BARI: -1.02

Barak Investment House Debt-to-Equity Historical Data

The historical data trend for Barak Investment House's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Barak Investment House Debt-to-Equity Chart

Barak Investment House Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial 0.06 0.49 1.42 -1.76 -1.02

Barak Investment House Quarterly Data
Jun18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23 Dec23
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.50 -2.77 -1.76 -1.50 -1.02

Competitive Comparison of Barak Investment House's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Barak Investment House's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Barak Investment House's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Barak Investment House's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Barak Investment House's Debt-to-Equity falls into.



Barak Investment House Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Barak Investment House's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Barak Investment House's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Barak Investment House  (XTAE:BARI) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Barak Investment House Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Barak Investment House's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Barak Investment House (XTAE:BARI) Business Description

Traded in Other Exchanges
N/A
Address
Jabotinsky Street 7, Ramat Gan, ISR, 52520
Panaxia Labs Israel Ltd is engaged in the manufacture and distribution of medical cannabis products. The firm offers a wide range of products comprising oral tablets, sublingual tablets, medical oils, concentrations, pastilles, suppositories, topical creams, pain relief creams, and pain relief patches.

Barak Investment House (XTAE:BARI) Headlines

No Headlines